Allogene Therapeutics, Inc. Annual Depreciation in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Allogene Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from 2018 to 2023.
  • Allogene Therapeutics, Inc. Depreciation for the quarter ending March 31, 2024 was $3.56M, a 1.37% increase year-over-year.
  • Allogene Therapeutics, Inc. annual Depreciation for 2023 was $14.2M, a 0.67% decline from 2022.
  • Allogene Therapeutics, Inc. annual Depreciation for 2022 was $14.3M, a 36.7% increase from 2021.
  • Allogene Therapeutics, Inc. annual Depreciation for 2021 was $10.5M, a 40.6% increase from 2020.
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $14.2M -$96K -0.67% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-14
2022 $14.3M +$3.84M +36.7% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-14
2021 $10.5M +$3.02M +40.6% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-14
2020 $7.44M +$3.01M +68.1% Jan 1, 2020 Dec 31, 2020 10-K/A 2024-03-14
2019 $4.42M +$3.38M +322% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-23
2018 $1.05M Jan 1, 2018 Dec 31, 2018 10-K 2021-02-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.